JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB230946

Anti-ICOS Ligand/ICOSL 抗体 [EPR20786]

Anti-ICOS Ligand/ICOSL antibody [EPR20786]

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Recombinant Monoclonal ICOS Ligand/ICOSL antibody. Suitable for IP, WB and reacts with Human samples. Cited in 1 publication.

別名を表示する

CD275, B7H2, B7RP1, ICOSL, KIAA0653, ICOSLG, ICOS ligand, B7 homolog 2, B7-like protein Gl50, B7-related protein 1, B7-H2, B7RP-1

4 Images
Immunoprecipitation - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)
  • IP

Supplier Data

Immunoprecipitation - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)

ICOS Ligand/ICOSL was immunoprecipitated from 0.35 mg JAR (human placenta choriocarcinoma cell line) whole cell lysate with ab230946 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab230946 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

Lane 1 : JAR (human placenta choriocarcinoma cell line) whole cell lysate 10 μg (Input).
Lane 2 : ab230946 IP in JAR whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab230946 in JAR whole cell lysate (-).

Blocking/Dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.

All lanes:

Immunoprecipitation - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (ab230946)

Predicted band size: 33 kDa

Observed band size: 60 kDa

false

Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)
  • WB

Supplier Data

Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)

Blocking and diluting buffer : 5% NFDM/TBST.

Exposure times :

Lane 1 : 15 seconds.

Lane 2 : 84 seconds.

ICOS ligand/ICOSL is highly glycosylated (PMID11983910).

All lanes:

Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (ab230946) at 1/1000 dilution

Lane 1:

HuT-78 (human Sezary syndrome cutaneous T lymphocyte) whole cell lysate at 20 µg

Lane 2:

JAR (human placenta choriocarcinoma cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 33 kDa

Observed band size: 60 kDa

false

Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)
  • WB

Supplier Data

Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)

Blocking and diluting buffer : 5% NFDM/TBST.

Exposure time : 58 seconds.

The level of ICOS Ligand/ICOSL expression can be elevated by TNF-alpha treatment (PMID 11983910,PMID16049332).

All lanes:

Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (ab230946) at 1/1000 dilution

Lane 1:

Untreated HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 10 µg

Lane 2:

HUVEC whole cell lysate treated with tumor necrosis factor (TNF-alpha, <a href='/products/proteins-peptides/recombinant-human-tnf-alpha-protein-ab9642'>ab9642</a>) 200 unit/ml for 24 hours at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 33 kDa

Observed band size: 60 kDa

false

Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)
  • WB

Supplier Data

Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)

Blocking and dilution buffer : 5% NFDM/TBST.

Exposure time : 15 seconds.

All lanes:

Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (ab230946) at 1/1000 dilution

All lanes:

His-tagged recombinant human ICOS ligand/ICOSL protein (aa19-258) at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 33 kDa

Observed band size: 55 kDa

false

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-ICOS Ligand/ICOSL antibody [EPR20786] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR20786

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

IP, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Conditional Ambient
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The ICOS Ligand also known as ICOSL B7-H2 and HK53 is a critical component in immune system function. This protein with a molecular mass of approximately 65 kDa is expressed on professional antigen-presenting cells such as dendritic cells macrophages and B cells. It plays a significant mechanical role in the immune response by engaging with its counter receptor the ICOS protein present on the surface of activated T cells. This interaction supports the regulation of T cell activity influencing proliferation and cytokine production.
Biological function summary

ICOSL contributes to the modulation of immune responses. By forming a complex with the active ICOS protein ICOSL is involved in the co-stimulation of T cells. This process is important for the development of T-cell-dependent immune responses and helps in promoting the survival and differentiation of T cells. Together the ICOS ligand and ICOS protein create a dynamic interaction that balances immune activation and tolerance which is essential for maintaining immune homeostasis.

Pathways

The ICOS-ICOSL interaction plays an important role in the T-cell receptor (TCR) signaling pathway. This pathway is fundamental for the activation of T cells and subsequent immune response. ICOSL also connects to the PI3K/Akt pathway where it impacts cell survival and proliferation. ICOS and the PI3K/Akt pathway work together to influence various aspects of immune regulation and adaptive immunity.

ICOSL has a notable impact on autoimmune diseases and cancer. Its function in immune modulation when dysregulated can contribute to autoimmune conditions such as systemic lupus erythematosus. In this context the abnormal activation of the ICOS protein may exaggerate immune responses leading to pathology. In cancer high expression of ICOSL can support tumor progression by affecting the immune surveillance capability. These associations reveal ICOSL’s role in balancing immune activation and inhibition which is important in the context of disease.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Ligand for the T-cell-specific cell surface receptor ICOS. Acts as a costimulatory signal for T-cell proliferation and cytokine secretion (PubMed : 11007762, PubMed : 11023515, PubMed : 30498080). Also induces B-cell proliferation and differentiation into plasma cells. Could play an important role in mediating local tissue responses to inflammatory conditions, as well as in modulating the secondary immune response by co-stimulating memory T-cell function (By similarity). In endothelial cells, required for proper neutrophil transmigration in response to chemoattractants, such as CXCL8/IL8 or N-formyl-methionyl peptides (fMLP) (PubMed : 30498080).
See full target information ICOSLG

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

Microorganisms 11: PubMed36838330

2023

SLAMF7/STAT6 Pathway Inhibits Innate Immune Response in Late-Stage Human Keratitis: A Comparative Transcriptome Analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenyu Wei,Yuheng Zhang,Qiankun Chen,Xizhan Xu,Zhiqiang Pan,Zi-Bing Jin,Qingfeng Liang
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com